Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial.
Conclusion: MS had no independent association with RGL risk. Adjustment for renal function attenuated the association between MS and RGL.
PMID: 21725919 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)
